One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving
Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. We investigated the efficacy of one session of high frequency repetitive tra...
Saved in:
| Published in | Drug and alcohol dependence Vol. 86; no. 1; pp. 91 - 94 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Shannon
Elsevier Ireland Ltd
05.01.2007
Elsevier Science |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0376-8716 1879-0046 |
| DOI | 10.1016/j.drugalcdep.2006.06.002 |
Cover
Loading…
| Abstract | Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex.
We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10
Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4
h after rTMS we measured craving using visual analogue scales.
Right, but not left, DLPFC stimulation significantly reduced craving over time (
F(2,10)
=
11.07,
p
=
0.0029). The reduction was 19% (13.4–24.6%) from baseline and disappeared after 4
h. The interaction of time by site of stimulation for craving was also significant (
F(2,25)
=
6.13,
p
=
0.0068).
One session of 10
Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction. |
|---|---|
| AbstractList | Background: Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. Methods: We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10 Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4 h after rTMS we measured craving using visual analogue scales. Results: Right, but not left, DLPFC stimulation significantly reduced craving over time (F(2,10)= 11.07, p = 0.0029). The reduction was 19% (13.4-24.6%) from baseline and disappeared after 4 h. The interaction of time by site of stimulation for craving was also significant (F(2,25) = 6.13, p = 0.0068). Conclusion: One session of 10 Hz rTMS over right, but not left, DLPFC transientiy reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive heuromodulation as a therapeutic tool for cocaine addiction. [Copyright 2006 Elsevier Ireland Ltd.] Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4h after rTMS we measured craving using visual analogue scales. Right, but not left, DLPFC stimulation significantly reduced craving over time (F(2,10)=11.07, p=0.0029). The reduction was 19% (13.4-24.6%) from baseline and disappeared after 4h. The interaction of time by site of stimulation for craving was also significant (F(2,25)=6.13, p=0.0068). One session of 10Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction. Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex.BACKGROUNDCocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex.We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4h after rTMS we measured craving using visual analogue scales.METHODSWe investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4h after rTMS we measured craving using visual analogue scales.Right, but not left, DLPFC stimulation significantly reduced craving over time (F(2,10)=11.07, p=0.0029). The reduction was 19% (13.4-24.6%) from baseline and disappeared after 4h. The interaction of time by site of stimulation for craving was also significant (F(2,25)=6.13, p=0.0068).RESULTSRight, but not left, DLPFC stimulation significantly reduced craving over time (F(2,10)=11.07, p=0.0029). The reduction was 19% (13.4-24.6%) from baseline and disappeared after 4h. The interaction of time by site of stimulation for craving was also significant (F(2,25)=6.13, p=0.0068).One session of 10Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction.CONCLUSIONOne session of 10Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction. Abstract Background Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. Methods We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10 Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4 h after rTMS we measured craving using visual analogue scales. Results Right, but not left, DLPFC stimulation significantly reduced craving over time ( F (2,10) = 11.07, p = 0.0029). The reduction was 19% (13.4–24.6%) from baseline and disappeared after 4 h. The interaction of time by site of stimulation for craving was also significant ( F (2,25) = 6.13, p = 0.0068). Conclusion One session of 10 Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction. Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10 Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4 h after rTMS we measured craving using visual analogue scales. Right, but not left, DLPFC stimulation significantly reduced craving over time ( F(2,10) = 11.07, p = 0.0029). The reduction was 19% (13.4–24.6%) from baseline and disappeared after 4 h. The interaction of time by site of stimulation for craving was also significant ( F(2,25) = 6.13, p = 0.0068). One session of 10 Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction. Background Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to changes in brain activity in networks involving the prefrontal cortex. Methods We investigated the efficacy of one session of high frequency repetitive transcranial magnetic stimulation (rTMS) to reduce craving in cocaine addicted subjects. Six patients underwent two sessions of 10 Hz rTMS over left or right dorsolateral prefrontal cortex (DLPFC). Before, immediately after and 4 h after rTMS we measured craving using visual analogue scales. Results Right, but not left, DLPFC stimulation significantly reduced craving over time (F(2,10) = 11.07, p = 0.0029). The reduction was 19% (13.4-24.6%) from baseline and disappeared after 4 h. The interaction of time by site of stimulation for craving was also significant (F(2,25) = 6.13, p = 0.0068). Conclusion One session of 10 Hz rTMS over right, but not left, DLPFC transiently reduces craving in cocaine dependent individuals. These results highlight the potential of non-invasive neuromodulation as a therapeutic tool for cocaine addiction. |
| Author | Alonso-Alonso, Miguel Camprodon, Joan Albert Martínez-Raga, José Pascual-Leone, Alvaro Shih, Mei-Chiung |
| Author_xml | – sequence: 1 givenname: Joan Albert surname: Camprodon fullname: Camprodon, Joan Albert organization: Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, KS 452, Boston, MA 02215, USA – sequence: 2 givenname: José surname: Martínez-Raga fullname: Martínez-Raga, José organization: Instituto de Drogas y Conductas Adictivas (IDYCA), Universidad Cardenal Herrera–CEU, Unidad de Conductas Adictivas Area 11, Agencia Valenciana de Salud, Spain – sequence: 3 givenname: Miguel surname: Alonso-Alonso fullname: Alonso-Alonso, Miguel organization: Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, KS 452, Boston, MA 02215, USA – sequence: 4 givenname: Mei-Chiung surname: Shih fullname: Shih, Mei-Chiung organization: Department of Biostatistics, Harvard School of Public Health and Clinical Research Program, Children's Hospital Boston, 333 Longwood Avenue, Boston, MA 02115, USA – sequence: 5 givenname: Alvaro surname: Pascual-Leone fullname: Pascual-Leone, Alvaro email: apleone@bidmc.harvard.edu organization: Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, KS 452, Boston, MA 02215, USA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18460731$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16971058$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVkl9v0zAUxSM0xLrBV0B-AcFDy7UTO8kLAib-SUN72Hi2XOemdUmdznYq-j34wNzQQiUktBFZ8YN_5-ja55xlJ773mGWMw4wDV69WsyYMC9PZBjczAaBm4wLxIJvwqqynAIU6ySaQl2palVydZmcxroA-VcOj7JSruuQgq0n248ojixij6z3rW7Z0iyVrA94O6O2OBdxgcsltkaVgfLT0c6Zja7PwdGBZTG49dCaN8hfh5sv1S5Z6lpbIAjkltgnYht4n0tg-JPy-93HoUzfaN4PFSEfWOBqE7LfOLx5nD1vTRXxy2M-zrx_e31x8ml5effx88fZyamWp0rSaF6oC3vKiBIGoRGVKkJBLLvNatoi5aJSQc8uxlaLNwRa1aZpCNHPOsczz8-z53ncTerpwTHrtosWuMx77IWpV5VJxUd8JypJLWRF-FyhAFmUFisCnB3CYr7HRm-DWJuz072QIeHYATLSma-nVrItHrioUlDknrtpzNvQx0msfEdBjWfRKH8uix7LocYEg6eu_pNalX1FSRq67j8G7vQFSSFuHQUdLyVpsXECbdNO7_5jij4ntnHd052-4w7jqh-CpBJrrKDTo67HUY6dBkVoISQZv_m1wvxl-At4GDqw |
| CODEN | DADEDV |
| CitedBy_id | crossref_primary_10_1016_j_brainres_2015_03_048 crossref_primary_10_1080_15622975_2017_1355472 crossref_primary_10_1007_s11836_011_0165_z crossref_primary_10_1016_j_clinph_2014_05_021 crossref_primary_10_1126_scitranslmed_3002902 crossref_primary_10_1007_s40473_017_0135_4 crossref_primary_10_1016_j_neurot_2024_e00451 crossref_primary_10_1016_j_psychres_2022_114904 crossref_primary_10_1016_j_nurt_2010_03_002 crossref_primary_10_1126_science_315_5819_1663c crossref_primary_10_1176_appi_focus_20180042 crossref_primary_10_1093_cercor_bhx331 crossref_primary_10_1016_j_neulet_2019_134400 crossref_primary_10_3390_jcm10235595 crossref_primary_10_1111_adb_12415 crossref_primary_10_1111_j_1465_3362_2009_00028_x crossref_primary_10_1016_j_appet_2007_09_016 crossref_primary_10_1093_scan_nss132 crossref_primary_10_1016_j_biopsych_2009_11_023 crossref_primary_10_1016_j_lpm_2010_01_001 crossref_primary_10_1186_1744_9081_4_34 crossref_primary_10_1177_1529100619860513 crossref_primary_10_3109_15622975_2011_598383 crossref_primary_10_3389_fpsyt_2019_00317 crossref_primary_10_1016_j_eurpsy_2017_06_012 crossref_primary_10_1111_ejn_14313 crossref_primary_10_3389_fnins_2020_00208 crossref_primary_10_1186_s10194_017_0792_4 crossref_primary_10_3109_09540261_2011_618827 crossref_primary_10_1176_appi_ajp_20240403 crossref_primary_10_1111_j_1360_0443_2009_02777_x crossref_primary_10_1002_eat_23597 crossref_primary_10_1176_appi_neuropsych_16040065 crossref_primary_10_1016_j_brs_2013_12_002 crossref_primary_10_1093_braincomms_fcab120 crossref_primary_10_1016_j_nicl_2023_103490 crossref_primary_10_1001_jamanetworkopen_2020_0910 crossref_primary_10_1080_17434440_2024_2404962 crossref_primary_10_1016_j_appet_2014_03_010 crossref_primary_10_1016_j_paid_2011_02_032 crossref_primary_10_1016_j_ijpsycho_2017_03_001 crossref_primary_10_1080_00952990_2020_1849247 crossref_primary_10_1016_j_pnpbp_2015_11_003 crossref_primary_10_1590_S1807_55092013005000009 crossref_primary_10_1192_apt_bp_115_014563 crossref_primary_10_1186_s13063_020_4074_0 crossref_primary_10_1016_j_neuroscience_2014_06_042 crossref_primary_10_3390_brainsci13071072 crossref_primary_10_3389_fnins_2020_00137 crossref_primary_10_1016_j_drugalcdep_2014_12_026 crossref_primary_10_1177_2045125317743435 crossref_primary_10_1016_j_biopsych_2016_02_006 crossref_primary_10_1016_j_neulet_2016_06_049 crossref_primary_10_1371_journal_pone_0212312 crossref_primary_10_1016_j_bbr_2018_07_004 crossref_primary_10_1097_ADT_0000000000000169 crossref_primary_10_1111_j_1460_9568_2009_06991_x crossref_primary_10_1007_s10072_021_05799_7 crossref_primary_10_1126_science_1145590 crossref_primary_10_1016_j_pnpbp_2018_12_018 crossref_primary_10_1093_brain_aww284 crossref_primary_10_1586_erd_09_64 crossref_primary_10_1007_s11307_015_0859_z crossref_primary_10_1016_j_brs_2012_06_008 crossref_primary_10_1111_j_1360_0443_2008_02448_x crossref_primary_10_3389_fphar_2018_01198 crossref_primary_10_1016_j_jns_2014_01_037 crossref_primary_10_3389_fpsyt_2024_1441815 crossref_primary_10_1016_j_drugalcdep_2015_11_018 crossref_primary_10_1176_appi_neuropsych_13010013 crossref_primary_10_1007_s11892_019_1250_2 crossref_primary_10_1016_j_drugalcdep_2013_08_012 crossref_primary_10_3389_fnins_2019_01147 crossref_primary_10_1016_j_bpsc_2021_01_003 crossref_primary_10_3389_fpsyt_2022_793938 crossref_primary_10_1111_ajad_12638 crossref_primary_10_1038_nrn_2017_113 crossref_primary_10_1155_2014_815215 crossref_primary_10_3390_ijerph192316082 crossref_primary_10_1016_j_drugalcdep_2011_07_021 crossref_primary_10_1016_j_neucli_2018_10_002 crossref_primary_10_1080_23279095_2021_1907392 crossref_primary_10_1177_1078390309346845 crossref_primary_10_1101_sqb_2018_83_038158 crossref_primary_10_3390_jcm8060768 crossref_primary_10_1016_j_jpsychires_2014_03_007 crossref_primary_10_3390_brainsci12010048 crossref_primary_10_1002_da_22252 crossref_primary_10_1038_s44220_023_00154_5 crossref_primary_10_1007_s10143_020_01415_y crossref_primary_10_1523_JNEUROSCI_3283_07_2007 crossref_primary_10_3109_00048674_2011_615294 crossref_primary_10_1038_tp_2011_6 crossref_primary_10_1111_nyas_12985 crossref_primary_10_1016_j_drugalcdep_2017_01_037 crossref_primary_10_1192_bjpo_bp_115_000315 crossref_primary_10_1016_j_psychres_2022_114431 crossref_primary_10_1007_s10865_013_9535_4 crossref_primary_10_1093_psyrad_kkab016 crossref_primary_10_2147_SAR_S337338 crossref_primary_10_61186_jrums_23_8_691 crossref_primary_10_1016_j_pnpbp_2022_110513 crossref_primary_10_1038_npp_2016_114 crossref_primary_10_1371_journal_pone_0259860 crossref_primary_10_1016_j_drugalcdep_2010_06_019 crossref_primary_10_1080_00952990_2017_1355920 crossref_primary_10_1016_j_alcohol_2018_05_011 crossref_primary_10_1016_j_neubiorev_2015_10_001 crossref_primary_10_1016_j_neubiorev_2023_105477 crossref_primary_10_1038_s41598_020_80927_5 crossref_primary_10_1124_pr_116_013649 crossref_primary_10_1177_10998004221122522 crossref_primary_10_3389_fnhum_2014_00661 crossref_primary_10_1038_npp_2016_80 crossref_primary_10_1016_j_eurpsy_2016_11_001 crossref_primary_10_3389_fpsyt_2020_561246 crossref_primary_10_1016_j_addbeh_2020_106760 crossref_primary_10_1016_j_bpsc_2018_03_016 crossref_primary_10_1016_j_drugalcdep_2014_03_036 crossref_primary_10_1111_ejn_14194 crossref_primary_10_1016_j_bpsc_2024_11_022 crossref_primary_10_1016_j_brs_2012_03_009 crossref_primary_10_1016_j_brainres_2015_02_053 crossref_primary_10_1016_j_neubiorev_2014_10_013 crossref_primary_10_1038_nrn2169 crossref_primary_10_3389_fnhum_2018_00344 crossref_primary_10_3109_10826084_2010_482434 crossref_primary_10_1016_j_neuropharm_2012_06_045 crossref_primary_10_1016_j_neulet_2022_136588 crossref_primary_10_3389_fpsyt_2016_00133 crossref_primary_10_2217_fnl_2017_0004 crossref_primary_10_1016_j_neubiorev_2018_09_013 crossref_primary_10_1016_j_addbeh_2012_07_002 crossref_primary_10_1016_j_ebiom_2020_102809 crossref_primary_10_1016_j_neubiorev_2019_06_007 crossref_primary_10_1016_j_neubiorev_2009_11_006 crossref_primary_10_3389_fnins_2019_00765 crossref_primary_10_1007_s11682_017_9800_1 crossref_primary_10_1111_ajad_12309 crossref_primary_10_1016_j_neurom_2022_03_002 crossref_primary_10_1073_pnas_1405003111 crossref_primary_10_1016_j_drugalcdep_2007_06_011 crossref_primary_10_1159_000357941 crossref_primary_10_1097_JCP_0b013e318252464f crossref_primary_10_1111_ejn_15172 crossref_primary_10_1016_j_pbb_2021_173240 crossref_primary_10_1080_10550887_2021_2007716 crossref_primary_10_1186_s12888_024_06137_9 crossref_primary_10_1016_j_jad_2014_11_015 crossref_primary_10_1017_S1461145714000686 crossref_primary_10_1111_ajad_12674 crossref_primary_10_1016_j_euroneuro_2015_11_011 crossref_primary_10_1111_nyas_12479 crossref_primary_10_1002_wcs_1492 crossref_primary_10_1016_j_neuropsychologia_2013_09_016 crossref_primary_10_1016_j_neures_2010_06_013 crossref_primary_10_1016_j_addbeh_2019_05_006 crossref_primary_10_1016_j_ajp_2011_03_003 crossref_primary_10_1016_j_neubiorev_2021_02_014 crossref_primary_10_1371_journal_pone_0136182 crossref_primary_10_3233_JPD_171290 crossref_primary_10_3389_fpsyt_2018_00080 crossref_primary_10_1016_j_bpsc_2017_07_003 crossref_primary_10_1016_j_neures_2022_12_014 crossref_primary_10_1523_JNEUROSCI_5587_09_2010 crossref_primary_10_1016_j_jns_2020_117149 crossref_primary_10_1016_j_coph_2020_11_001 crossref_primary_10_3389_fpsyt_2019_00621 crossref_primary_10_3389_fpsyt_2020_00158 crossref_primary_10_1016_j_brs_2016_07_002 crossref_primary_10_1016_j_neubiorev_2013_07_009 |
| Cites_doi | 10.1523/JNEUROSCI.21-15-j0003.2001 10.4088/JCP.v64n0815 10.1212/WNL.46.2.499 10.1016/S0140-6736(96)01219-6 10.1002/(SICI)1099-1077(199904)14:3<161::AID-HUP73>3.0.CO;2-2 10.1176/appi.ajp.157.11.1789 10.1176/appi.ajp.159.10.1642 10.1016/S0893-133X(01)00371-2 10.1016/j.biopsych.2005.05.043 10.1162/089892903770007344 10.1097/00004691-200208000-00007 10.1038/nn1200 10.1038/nn1584 10.1176/ajp.155.1.124 10.1016/j.neuropharm.2004.07.019 10.1016/S0168-5597(97)00096-8 10.1176/appi.ajp.160.5.835 10.1016/j.tips.2004.02.005 |
| ContentType | Journal Article |
| Copyright | 2006 Elsevier Ireland Ltd Elsevier Ireland Ltd 2007 INIST-CNRS |
| Copyright_xml | – notice: 2006 Elsevier Ireland Ltd – notice: Elsevier Ireland Ltd – notice: 2007 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7QJ 7X8 |
| DOI | 10.1016/j.drugalcdep.2006.06.002 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Applied Social Sciences Index & Abstracts (ASSIA) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts Applied Social Sciences Index and Abstracts (ASSIA) MEDLINE - Academic |
| DatabaseTitleList | Applied Social Sciences Index and Abstracts (ASSIA) MEDLINE MEDLINE - Academic Neurosciences Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Social Welfare & Social Work |
| EISSN | 1879-0046 |
| EndPage | 94 |
| ExternalDocumentID | 16971058 18460731 10_1016_j_drugalcdep_2006_06_002 S0376871606002225 1_s2_0_S0376871606002225 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCRR NIH HHS grantid: K24 RR018875 |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ 9JM 9JO AABNK AAEDT AAEDW AAFJI AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABIVO ABJNI ABLJU ABMAC ABMMH ABMZM ABWVN ABXDB ABZDS ACDAQ ACGFS ACHQT ACIEU ACIUM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOMHK APXCP ASPBG AVARZ AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEG HMK HMO HVGLF HZ~ H~9 IHE J1W KOM M29 M39 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OH0 OU- OZT P-8 P-9 P2P PC. PRBVW Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSB SSH SSN SSO SSP SSZ T5K TN5 UAP WH7 WUQ XPP Z5R ZGI ZXP ZY4 ~G- 0SF AACTN ABTAH AFCTW AFKWA AJOXV AMFUW NCXOZ PKN RIG AADPK AAIAV AATCM ABLVK ABYKQ AJBFU AKYCK EFLBG LCYCR AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7TK 7QJ 7X8 |
| ID | FETCH-LOGICAL-c576t-8b46801f14702ee628a70503515395fee32d625bc1ef52f30c49add42db11e733 |
| IEDL.DBID | .~1 |
| ISSN | 0376-8716 |
| IngestDate | Thu Sep 04 23:11:38 EDT 2025 Fri Sep 05 08:24:17 EDT 2025 Fri Sep 05 00:00:55 EDT 2025 Wed Feb 19 01:43:09 EST 2025 Mon Jul 21 09:16:43 EDT 2025 Tue Jul 01 00:52:02 EDT 2025 Thu Apr 24 22:51:52 EDT 2025 Fri Feb 23 02:31:22 EST 2024 Sun Feb 23 10:18:53 EST 2025 Tue Aug 26 17:03:43 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Transcranial magnetic stimulation (TMS) Cocaine Dorsolateral prefrontal cortex (DLPFC) Addiction Craving Human Drug addiction Transcranial magnetic stimulation CNS stimulant Psychotropic Psychology Dorsolateral cortex Central nervous system Right Prefrontal cortex Encephalon Ester Magnetic stimulus Frequency Drug of abuse Psychiatry |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c576t-8b46801f14702ee628a70503515395fee32d625bc1ef52f30c49add42db11e733 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 16971058 |
| PQID | 20547806 |
| PQPubID | 23462 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_68356129 proquest_miscellaneous_57155868 proquest_miscellaneous_20547806 pubmed_primary_16971058 pascalfrancis_primary_18460731 crossref_primary_10_1016_j_drugalcdep_2006_06_002 crossref_citationtrail_10_1016_j_drugalcdep_2006_06_002 elsevier_sciencedirect_doi_10_1016_j_drugalcdep_2006_06_002 elsevier_clinicalkeyesjournals_1_s2_0_S0376871606002225 elsevier_clinicalkey_doi_10_1016_j_drugalcdep_2006_06_002 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2007-01-05 |
| PublicationDateYYYYMMDD | 2007-01-05 |
| PublicationDate_xml | – month: 01 year: 2007 text: 2007-01-05 day: 05 |
| PublicationDecade | 2000 |
| PublicationPlace | Shannon |
| PublicationPlace_xml | – name: Shannon – name: Ireland |
| PublicationTitle | Drug and alcohol dependence |
| PublicationTitleAlternate | Drug Alcohol Depend |
| PublicationYear | 2007 |
| Publisher | Elsevier Ireland Ltd Elsevier Science |
| Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier Science |
| References | Garavan, Pankiewicz, Bloom, Cho, Sperry, Ross, Salmeron, Risinger, Kelley, Stein (bib4) 2000; 157 Substance Abuse and Mental Health Services Administration, 2003. Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774), Rockville, MD. Wilson, Sayette, Fiez (bib20) 2004; 7 Uher, Yoganathan, Mogg, Eranti, Treasure, Campbell, McLoughlin, Schmidt (bib17) 2005; 58 Volkow, Fowler, Wang (bib18) 2004; 47 Pascual-Leone, Rubio, Pallardó, Catalá (bib12) 1996; 348 Pascual-Leone, Catalá, Pascual-Leone Pascual (bib13) 1996; 46 Strafella, Paus, Barret, Dagher (bib15) 2001; 21 Maas, Lukas, Kaufman, Weiss, Daniels, Rogers, Kukes, Renshaw (bib9) 1998; 155 Bechara (bib1) 2005; 8 Office of National Drug Control Policy, 2001. The Economic Costs of Drug Abuse in the United States, 1992–1998. Executive Office of the President (Publication No. NCJ-190636), Washington, DC. Gershon, Dannon, Grunhaus (bib6) 2003; 160 Nestler (bib10) 2004; 25 George, Stallings, Speer, Nahas, Spicer, Vincent, Bohning, Cheng, Molloy, Teneback, Risch (bib5) 1999; 14 Robertson, Theoret, Pascual-Leone (bib14) 2003; 15 Eichhammer, Johann, Kharraz, Binder, Pittrow, Wodarz, Hajak (bib3) 2003; 64 Goldstein, Volkow (bib7) 2002; 159 Wassermann (bib19) June 5–7, 1996; 108 Bonson, Grant, Contoreggi, Links, Metcalfe, Weyl, Kurian, Ernst, London (bib2) 2002; 26 Lisanby, Kinnunen, Crupain (bib8) 2002; 19 Strafella (10.1016/j.drugalcdep.2006.06.002_bib15) 2001; 21 Nestler (10.1016/j.drugalcdep.2006.06.002_bib10) 2004; 25 Bonson (10.1016/j.drugalcdep.2006.06.002_bib2) 2002; 26 10.1016/j.drugalcdep.2006.06.002_bib11 Eichhammer (10.1016/j.drugalcdep.2006.06.002_bib3) 2003; 64 Gershon (10.1016/j.drugalcdep.2006.06.002_bib6) 2003; 160 Volkow (10.1016/j.drugalcdep.2006.06.002_bib18) 2004; 47 George (10.1016/j.drugalcdep.2006.06.002_bib5) 1999; 14 Uher (10.1016/j.drugalcdep.2006.06.002_bib17) 2005; 58 Lisanby (10.1016/j.drugalcdep.2006.06.002_bib8) 2002; 19 Pascual-Leone (10.1016/j.drugalcdep.2006.06.002_bib12) 1996; 348 10.1016/j.drugalcdep.2006.06.002_bib16 Maas (10.1016/j.drugalcdep.2006.06.002_bib9) 1998; 155 Goldstein (10.1016/j.drugalcdep.2006.06.002_bib7) 2002; 159 Bechara (10.1016/j.drugalcdep.2006.06.002_bib1) 2005; 8 Wilson (10.1016/j.drugalcdep.2006.06.002_bib20) 2004; 7 Robertson (10.1016/j.drugalcdep.2006.06.002_bib14) 2003; 15 Wassermann (10.1016/j.drugalcdep.2006.06.002_bib19) 1996; 108 Garavan (10.1016/j.drugalcdep.2006.06.002_bib4) 2000; 157 Pascual-Leone (10.1016/j.drugalcdep.2006.06.002_bib13) 1996; 46 |
| References_xml | – volume: 19 start-page: 344 year: 2002 end-page: 360 ident: bib8 article-title: Applications of TMS to therapy in psychiatry publication-title: J. Clin. Neurophysiol. – volume: 155 start-page: 124 year: 1998 end-page: 126 ident: bib9 article-title: Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving publication-title: Am. J. Psychiatry – volume: 160 start-page: 834 year: 2003 end-page: 835 ident: bib6 article-title: Transcranial magnetic stimulation in the treatment of depression publication-title: Am. J. Psychiatry – volume: 25 start-page: 210 year: 2004 end-page: 218 ident: bib10 article-title: Historical review: molecular and cellular mechanisms of opiate and cocaine addiction publication-title: Trends Pharmacol. Sci. – volume: 46 start-page: 499 year: 1996 end-page: 502 ident: bib13 article-title: Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood publication-title: Neurology – volume: 14 start-page: 161 year: 1999 end-page: 170 ident: bib5 article-title: Prefrontal repetitive transcranial magnetic stimulation (rTMS) changes relative perfusion locally and remotely publication-title: Hum. Psychopharmacol. Clin. Exp. – volume: 159 start-page: 1642 year: 2002 end-page: 1652 ident: bib7 article-title: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex publication-title: Am. J. Psychiatry – volume: 21 start-page: RC157 year: 2001 ident: bib15 article-title: Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus publication-title: J. Neurosci. – volume: 26 start-page: 376 year: 2002 end-page: 386 ident: bib2 article-title: Neural systems and cue-induced cocaine craving publication-title: Neuropsychopharmacology – volume: 64 start-page: 951 year: 2003 end-page: 953 ident: bib3 article-title: High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking publication-title: J. Clin. Psychiatry – volume: 8 start-page: 1458 year: 2005 end-page: 1463 ident: bib1 article-title: Decision making, impulse control and loss of willpower to resist drugs: a neurocogntiive perspective publication-title: Nat. Neurosci. – reference: Office of National Drug Control Policy, 2001. The Economic Costs of Drug Abuse in the United States, 1992–1998. Executive Office of the President (Publication No. NCJ-190636), Washington, DC. – volume: 157 start-page: 1789 year: 2000 end-page: 1798 ident: bib4 article-title: Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli publication-title: Am. J. Psychiatry – volume: 47 start-page: 3 year: 2004 end-page: 13 ident: bib18 article-title: The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies publication-title: Neuropharmacology – volume: 15 start-page: 948 year: 2003 end-page: 960 ident: bib14 article-title: Studies in cognition: the problems solved and created by transcranial magnetic stimulation publication-title: J. Cogn. Neurosci. – reference: Substance Abuse and Mental Health Services Administration, 2003. Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774), Rockville, MD. – volume: 7 start-page: 211 year: 2004 end-page: 214 ident: bib20 article-title: Prefrontal responses to drug cues: a neurocognitive analysis publication-title: Nat. Neurosci. – volume: 348 start-page: 233 year: 1996 end-page: 237 ident: bib12 article-title: Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression publication-title: Lancet – volume: 58 start-page: 840 year: 2005 end-page: 842 ident: bib17 article-title: Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving publication-title: Biol. Psychiatry – volume: 108 start-page: 1 year: June 5–7, 1996 end-page: 16 ident: bib19 article-title: Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the international workshop on the safety of repetitive transcranial magnetic stimulation publication-title: Electroencephalogr. Clin. Neurophysiol. – ident: 10.1016/j.drugalcdep.2006.06.002_bib11 – volume: 21 start-page: RC157 year: 2001 ident: 10.1016/j.drugalcdep.2006.06.002_bib15 article-title: Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.21-15-j0003.2001 – volume: 64 start-page: 951 year: 2003 ident: 10.1016/j.drugalcdep.2006.06.002_bib3 article-title: High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v64n0815 – volume: 46 start-page: 499 year: 1996 ident: 10.1016/j.drugalcdep.2006.06.002_bib13 article-title: Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood publication-title: Neurology doi: 10.1212/WNL.46.2.499 – volume: 348 start-page: 233 year: 1996 ident: 10.1016/j.drugalcdep.2006.06.002_bib12 article-title: Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression publication-title: Lancet doi: 10.1016/S0140-6736(96)01219-6 – volume: 14 start-page: 161 year: 1999 ident: 10.1016/j.drugalcdep.2006.06.002_bib5 article-title: Prefrontal repetitive transcranial magnetic stimulation (rTMS) changes relative perfusion locally and remotely publication-title: Hum. Psychopharmacol. Clin. Exp. doi: 10.1002/(SICI)1099-1077(199904)14:3<161::AID-HUP73>3.0.CO;2-2 – volume: 157 start-page: 1789 year: 2000 ident: 10.1016/j.drugalcdep.2006.06.002_bib4 article-title: Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.157.11.1789 – volume: 159 start-page: 1642 year: 2002 ident: 10.1016/j.drugalcdep.2006.06.002_bib7 article-title: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.159.10.1642 – volume: 26 start-page: 376 issue: 3 year: 2002 ident: 10.1016/j.drugalcdep.2006.06.002_bib2 article-title: Neural systems and cue-induced cocaine craving publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00371-2 – volume: 58 start-page: 840 year: 2005 ident: 10.1016/j.drugalcdep.2006.06.002_bib17 article-title: Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2005.05.043 – volume: 15 start-page: 948 issue: 7 year: 2003 ident: 10.1016/j.drugalcdep.2006.06.002_bib14 article-title: Studies in cognition: the problems solved and created by transcranial magnetic stimulation publication-title: J. Cogn. Neurosci. doi: 10.1162/089892903770007344 – volume: 19 start-page: 344 issue: 4 year: 2002 ident: 10.1016/j.drugalcdep.2006.06.002_bib8 article-title: Applications of TMS to therapy in psychiatry publication-title: J. Clin. Neurophysiol. doi: 10.1097/00004691-200208000-00007 – volume: 7 start-page: 211 year: 2004 ident: 10.1016/j.drugalcdep.2006.06.002_bib20 article-title: Prefrontal responses to drug cues: a neurocognitive analysis publication-title: Nat. Neurosci. doi: 10.1038/nn1200 – volume: 8 start-page: 1458 year: 2005 ident: 10.1016/j.drugalcdep.2006.06.002_bib1 article-title: Decision making, impulse control and loss of willpower to resist drugs: a neurocogntiive perspective publication-title: Nat. Neurosci. doi: 10.1038/nn1584 – volume: 155 start-page: 124 issue: 1 year: 1998 ident: 10.1016/j.drugalcdep.2006.06.002_bib9 article-title: Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving publication-title: Am. J. Psychiatry doi: 10.1176/ajp.155.1.124 – volume: 47 start-page: 3 issue: Suppl. 1 year: 2004 ident: 10.1016/j.drugalcdep.2006.06.002_bib18 article-title: The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2004.07.019 – volume: 108 start-page: 1 year: 1996 ident: 10.1016/j.drugalcdep.2006.06.002_bib19 article-title: Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the international workshop on the safety of repetitive transcranial magnetic stimulation publication-title: Electroencephalogr. Clin. Neurophysiol. doi: 10.1016/S0168-5597(97)00096-8 – ident: 10.1016/j.drugalcdep.2006.06.002_bib16 – volume: 160 start-page: 834 year: 2003 ident: 10.1016/j.drugalcdep.2006.06.002_bib6 article-title: Transcranial magnetic stimulation in the treatment of depression publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.160.5.835 – volume: 25 start-page: 210 year: 2004 ident: 10.1016/j.drugalcdep.2006.06.002_bib10 article-title: Historical review: molecular and cellular mechanisms of opiate and cocaine addiction publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2004.02.005 |
| SSID | ssj0000690 |
| Score | 2.326265 |
| Snippet | Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is related to... Abstract Background Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and... Background Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is... Background: Cocaine dependence is a public health problem affecting 2 million individuals in USA. Craving is a predictor of subsequent cocaine use and is... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 91 |
| SubjectTerms | Addiction Addictive behaviors Adult Adult and adolescent clinical studies Anxiety - epidemiology Biological and medical sciences Cocaine Cocaine-Related Disorders - diagnosis Cocaine-Related Disorders - epidemiology Cocaine-Related Disorders - physiopathology Cortex Craving Cross-Over Studies Disruptive, Impulse Control, and Conduct Disorders - diagnosis Disruptive, Impulse Control, and Conduct Disorders - epidemiology Disruptive, Impulse Control, and Conduct Disorders - physiopathology Dorsolateral prefrontal cortex (DLPFC) Drug addiction Functional Laterality - physiology Humans Male Medical sciences Neuropharmacology Pharmacology. Drug treatments Prefrontal Cortex - physiopathology Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Toxicology Transcranial magnetic stimulation (TMS) Transcranial Magnetic Stimulation - instrumentation |
| Title | One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0376871606002225 https://www.clinicalkey.es/playcontent/1-s2.0-S0376871606002225 https://dx.doi.org/10.1016/j.drugalcdep.2006.06.002 https://www.ncbi.nlm.nih.gov/pubmed/16971058 https://www.proquest.com/docview/20547806 https://www.proquest.com/docview/57155868 https://www.proquest.com/docview/68356129 |
| Volume | 86 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqckFCiDeBsviAEBzC2nk4iThVFdUCajm0Fb1ZtmNXhW0SJbsSXPgV_GBm4mSXiq60Epc9ZD1OHNvffJ7Mg5BXoDSUUpEODZDbMFHKhJoZFcZ5mqgsEtrbIY-Oxews-XSenu-QgzEWBt0qB-z3mN6j9XBlOrzNaXN5OT1hsDeQ7jPRR3RioHmSZJg__90v_hcaezsLNA6x9eDN4328ynYJOGxK2wyfJcTKwHKDirrTqA5enPMVLzZT0l41Hd4jdwdOSff9Y98nO7Z6QPZ84C39audOtZa-puOFuv3-kPz-Ulna-aQctHYU0xZT13rH6p-0tQ2GnwEU0gVqMwM_KHylLioMe6SADFdD5S_6pj09OnlLFzUFNkn74z5tYFiYGwFkDPrz_vD9YPTlHLsvYUl18JdRQHMpdI-GjUfk7PDD6cEsHCo0hAbOKYsw14kAFed4krHIWhHlKsMEM0CS4iJ11sZRCQcsbbh1aeRiZpICADWJSs25zeL4Mdmt6so-JbSMY8PTjBUaM-iZPE_iUitmmdbOaccCko2TIs2QvhyraMzl6Kf2Ta6nE6trCtm77EUB4SvJxqfw2EKmGOddjiGqAKoS9MwWstlNsrYb0KGTXHaRZPKfFRyQ9yvJa5tgy_tOri3Q9WCBYwKS84C8HFesBBDBL0OqsvWyg14wrRsTm1ukGRDPXOSbWwjg8kCXi4A88ZthfX9RAI9N82f_Nbzn5La3q_OQpXtkd9Eu7QsghAs96Xf8hNza__h5dvwHnXJknw |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKewCpQrxJKa0PCMEhWuflJOJUVVRb2l0O3YreLNuxq8I2iZKsBP-DH8w4dnap6EorcdlD1uPE8fibz5OZMULvwGhwzkPhSyC3fsy59AWR3I-yJOZpSIX1Q06mdHwZf7lKrrbQ8ZALY8IqHfZbTO_R2l0Zubc5qm9uRhcE1oah-4T2GZ3JA7RjqlOBsu8cnZ6Np38BsnW1QHvfCLiAHhvmVTQLgGJZqNp9maBLH8s9Vmq35i28O20PvVjPSnvrdPIEPXa0Eh_ZJ3-KtlT5DO3b3Fv8Tc01bxR-j4cLVfPjOfr9tVS4tXU5cKWxqVyMdWNjq3_hRtUmAw3QEHfGoEn4McK3_Lo0mY8YwOHWHf6FPzSzycVH3FUYCCXud_y4hmGZ8gggI01I70_bj0nAnJvuC9CqFv6SHJguhu6Nb-MFujz5PDse--6QBl_CVqXzMxFTsHI6iFMSKkXDjKemxgzwpChPtFJRWMAeS8hA6STUEZFxDpgah4UIApVG0Uu0XValeo1wEUUySFKSC1NET2ZZHBWCE0WE0Fpo4qF0mBQmXQVzc5DGnA2hat_ZajrNAZuU9VF7oYeCpWRtq3hsIJMP886GLFXAVQamZgPZ9D5Z1TqAaFnA2pAR9o8Se-jTUvLOOtjwvgd3FHQ1WKCZAOaBhw4HjWWAI-bjEC9VtWihF1PZjdD1LZIUuGdGs_UtKNB5YMy5h17ZxbC6P82ByibZ3n8N7xA9HM8m5-z8dHr2Bj2ybvbAJ8k-2u6ahXoL_LATB279_wGW5GdQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=One+session+of+high+frequency+repetitive+transcranial+magnetic+stimulation+%28rTMS%29+to+the+right+prefrontal+cortex+transiently+reduces+cocaine+craving&rft.jtitle=Drug+and+alcohol+dependence&rft.au=Camprodon%2C+Joan+Albert&rft.au=Mart%C3%ADnez-Raga%2C+Jos%C3%A9&rft.au=Alonso-Alonso%2C+Miguel&rft.au=Shih%2C+Mei-Chiung&rft.date=2007-01-05&rft.issn=0376-8716&rft.volume=86&rft.issue=1&rft.spage=91&rft_id=info:doi/10.1016%2Fj.drugalcdep.2006.06.002&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03768716%2FS0376871606X02806%2Fcov150h.gif |